CHICAGO--(BUSINESS WIRE)--CytoCore, Inc. (OTCBB:CYCR), a late-stage bio-scientific research company, today announced highly accurate results in using the P2X7 biomarker to detect bladder cancer -- suggesting much broader implications for its use in the early detection of cancer in all epithelial cells.
